Regeneron Pharmaceuticals (REGN) Inventory (2012 - 2026)

Regeneron Pharmaceuticals' Inventory history runs 15 years deep, the most recent figure standing at $3.1 billion for Q1 2026.

• In Q1 2026, Inventory fell 2.78% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (down 2.78% YoY), while the FY2025 annual figure was $3.2 billion, up 3.68% from the prior year.
• Inventory was $3.1 billion for Q1 2026 at Regeneron Pharmaceuticals, down from $3.2 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $3.3 billion in Q3 2025 to a low of $2.0 billion in Q1 2022.
• Historically, Inventory has averaged $2.7 billion across 5 years, with a median of $2.7 billion in 2024.
• Biggest YoY gain for Inventory was 23.09% in 2022; the steepest drop was 8.0% in 2022.
• A 5-year view of Inventory shows it stood at $2.4 billion in 2022, then rose by 7.44% to $2.6 billion in 2023, then increased by 19.64% to $3.1 billion in 2024, then grew by 3.68% to $3.2 billion in 2025, then retreated by 3.04% to $3.1 billion in 2026.
• The last three Inventory figures came in at $3.1 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.3 billion (Q3 2025), per Business Quant data.